Abstract: Thiazolidinedione compounds, compositions, and methods of inhibiting telomerase activity in vitro and treatment of telomerase mediated conditions or diseases ex vivo and in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of conditions or diseases mediated by telomerase activity, such as in the treatment of cancer. Also disclosed are novel methods for assaying or screening for inhibitors of telomerase activity.
Abstract: The invention provides DNA primase assays suitable for identifying DN primase modulating agents, methods of modulating DNA primase activity, compounds for modulating DNA primase activity, and compositions which modulate DNA primase.
Type:
Grant
Filed:
November 24, 1997
Date of Patent:
August 14, 2001
Assignee:
Geron Corporation
Inventors:
Michael R. Kozlowski, Junko Aimi, Ryan Holcomb
Abstract: A method of extracting telomerase from a cell sample having telomerase is provided which includes the step of contacting a cell sample with a buffer having (i) a non-ionic detergent at a concentration of not more than 5% (v/v) and (ii) an ionic detergent at a concentration of not more than 1 mM, to form a cell lysate. The method provides efficient extraction of telomerase that can be assayed for diagnostic and prognostic purposes.
Type:
Grant
Filed:
December 23, 1998
Date of Patent:
April 3, 2001
Assignee:
University of Texas Systems
Inventors:
Jerry W. Shay, Woodring E. Wright, James C. Norton, Jr.